Baidu Capital, Lake Bleu Capital among backers for lung disease diagnosis, treatment business Broncus


Lung disease diagnosis and treatment startup Broncus Holding Company has picked up a round of Series C investment from VC houses including Baidu Capital and Lake Bleu Capital.

Ascendum Capital, CNCB Capital, DCP Capital and previous backer Qiming Venture Capital also took part in the round for the China-based business.

Broncus said the funds will be used to further develop markets and technology across lung cancer, emphysema and other lung diseases.

Li Bin, founder of Lake Bleu Capital, said, “Broncus is Lake Bleu’s major investment in the medical device sector this year because they are addressing a large and unmet need globally in the diagnosis and treatment of lung diseases.

“Their world-leading Archimedes lung navigation technology is supported with robust data and uniquely helps physicians accurately locate and reach targeted lesions, which will open the door to new and exciting interventional lung therapies.

“We believe that Broncus is well positioned to lead the world in providing less invasive methods to diagnose and treat lung disease broadly.”


Copyright © 2020 AltAssets

Get the latest PE News & Research delivered to your inbox every morning